Category: Press + Publications

2. September 2025

AMW Strengthens Executive Leadership Team by Appointing Wolfram E. Scholl as Chief Operating Officer

Warngau, Germany, September 2, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today announced the appointment of Wolfram E. Scholl as Chief Operating Officer (COO) as of September 1, 2025. As long-standing expert and consultant in supply chain management, he is responsible for production, quality, supply chain, engineering and […]

24. July 2025

AMW Secures Successful Long-term Growth Financing from Raiffeisenlandesbank Oberösterreich

Warngau, Germany, July 24, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today announced the closing of a significant financing agreement. This long-term and attractive financing from Raiffeisenlandesbank Oberösterreich allowed the Company to optimize its financing structure and to gain access to an additional line of credit. “With another […]

27. May 2025

AMW and AdhexPharma Successfully Complete Strategic Transfer of Transdermal Delivery Systems

Warngau, Germany, Chenôve, France, May 27, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, and AdhexPharma SAS, an independent pharmaceutical company specializing in the development and manufacturing of patches and oral films, today announced the successful completion of the transfer of transdermal delivery systems (TDS) under the companies’ strategic […]

13. May 2025

AMW Reports Another Record Result for the 2024 Financial Year

Warngau, Germany, May 13, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today reported financial results for the year ended December 31, 2024. AMW posted another consolidated record revenue for 2024 of EUR 38.2 million, an increase of 30% compared to the previous year (2023: EUR 29.4 million). The […]

25. February 2025

AMW Pioneers Use of Artificial Intelligence in Formulation Development

Warngau, February 25, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today announced the launch of a research and development project to optimize formulation development using artificial intelligence (AI). The working group of Prof. Dr. Olivia Merkel, Chair of Drug Delivery at the Department of Pharmacy at Ludwig-Maximilians-Universität (LMU) […]

1. July 2024

AMW Appoints Additional Experts for Drug Delivery Systems to its Scientific Advisory Board

Warngau, Germany, July 1, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, today announced the appointment of Prof. Miriam Breunig, Senior Academic Councillor at the University of Regensburg’s Department of Pharmaceutical Technology, and Prof. Karsten Mäder, Professor of Pharmaceutics at Martin Luther University Halle-Wittenberg, as members to AMW’s Scientific […]